Summit Financial LLC lifted its stake in shares of KKR & Co. Inc. (NYSE:KKR – Free Report) by 20.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 9,650 shares of the asset manager’s stock after buying an additional 1,661 shares during the quarter. Summit Financial LLC’s holdings in KKR & Co. Inc. were worth $1,427,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors also recently modified their holdings of KKR. Farmers & Merchants Investments Inc. boosted its position in KKR & Co. Inc. by 17.8% during the 4th quarter. Farmers & Merchants Investments Inc. now owns 430 shares of the asset manager’s stock valued at $64,000 after acquiring an additional 65 shares in the last quarter. Oppenheimer Asset Management Inc. lifted its stake in shares of KKR & Co. Inc. by 0.4% in the 4th quarter. Oppenheimer Asset Management Inc. now owns 16,427 shares of the asset manager’s stock valued at $2,430,000 after purchasing an additional 69 shares during the period. Ballentine Partners LLC boosted its position in shares of KKR & Co. Inc. by 1.2% during the fourth quarter. Ballentine Partners LLC now owns 5,721 shares of the asset manager’s stock valued at $846,000 after purchasing an additional 70 shares in the last quarter. Parkside Financial Bank & Trust grew its stake in KKR & Co. Inc. by 5.7% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,289 shares of the asset manager’s stock worth $191,000 after purchasing an additional 70 shares during the period. Finally, Wealthcare Advisory Partners LLC raised its holdings in KKR & Co. Inc. by 0.7% in the fourth quarter. Wealthcare Advisory Partners LLC now owns 10,974 shares of the asset manager’s stock worth $1,623,000 after purchasing an additional 73 shares in the last quarter. Hedge funds and other institutional investors own 76.26% of the company’s stock.
KKR & Co. Inc. Stock Performance
Shares of NYSE KKR opened at $117.82 on Wednesday. The firm’s 50-day moving average price is $134.37 and its 200-day moving average price is $141.62. KKR & Co. Inc. has a 52-week low of $91.92 and a 52-week high of $170.40. The company has a market cap of $104.65 billion, a PE ratio of 35.38, a PEG ratio of 1.00 and a beta of 1.72. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.82.
KKR & Co. Inc. Dividend Announcement
Analysts Set New Price Targets
A number of analysts have recently commented on the stock. Hsbc Global Res cut shares of KKR & Co. Inc. from a “strong-buy” rating to a “hold” rating in a report on Thursday, January 30th. Wells Fargo & Company raised shares of KKR & Co. Inc. from an “equal weight” rating to an “overweight” rating and dropped their price objective for the stock from $150.00 to $141.00 in a research note on Thursday, March 20th. HSBC downgraded shares of KKR & Co. Inc. from a “buy” rating to a “hold” rating and raised their target price for the company from $153.00 to $173.00 in a research note on Thursday, January 30th. Barclays dropped their price target on KKR & Co. Inc. from $185.00 to $181.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 5th. Finally, Morgan Stanley cut their price target on KKR & Co. Inc. from $157.00 to $156.00 and set an “equal weight” rating on the stock in a research note on Thursday, February 6th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $160.79.
Read Our Latest Stock Report on KKR
Insider Buying and Selling at KKR & Co. Inc.
In other KKR & Co. Inc. news, major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of the business’s stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $32.96, for a total transaction of $197,760,000.00. Following the completion of the sale, the insider now directly owns 19,260,971 shares in the company, valued at $634,841,604.16. The trade was a 23.75 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 39.34% of the company’s stock.
KKR & Co. Inc. Company Profile
KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm’s business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.
Featured Articles
- Five stocks we like better than KKR & Co. Inc.
- Airline Stocks – Top Airline Stocks to Buy Now
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- The 3 Best Fintech Stocks to Buy Now
- Buffett Trims Equities, But Still Keeps Buying This Stock
Want to see what other hedge funds are holding KKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for KKR & Co. Inc. (NYSE:KKR – Free Report).
Receive News & Ratings for KKR & Co. Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KKR & Co. Inc. and related companies with MarketBeat.com's FREE daily email newsletter.